New Issue of NCCIH Update: ADHD & Complementary Approaches; New Acting Clinical Director

New Issue of NCCIH Update: ADHD & Complementary Approaches; New Acting Clinical Director

Announcements Clinical Digest: ADHD and Complementary Health Approaches According to a 2016 Centers for Disease Control and Prevention study, 6.1 million children (aged 2-17) living in the United States had been diagnosed with attention-deficit/hyperactivity disorder (ADHD). Although stimulant medications have been shown to be helpful for many children with ADHD, many adults and children use complementary health approaches such as omega-3 fatty acids, melatonin, herbs and other dietary supplements, special diets, neurofeedback, and several mind and body practices, including acupuncture and meditation to control ADHD symptoms. Many of these complementary health approaches have been studied for ADHD, but none has been conclusively shown to be more effective than conventional therapies. Dr. Brian Walitt Named Acting Clinical Director, NCCIH Intramural Program Brian Walitt, M.D., M.P.H., has joined NCCIH as Acting Clinical Director for our Intramural Research Program. Dr. Walitt brings a wealth of experience to the NCCIH intramural team. He is internationally known for his clinical and research work with fibromyalgia patients, and is the lead associate investigator on the NIH Myalgic Encephalitis/Chronic Fatigue Syndrome protocol. Dr. Walitt also holds the position of Medical Officer at both NINR and NIDCR, and is an Associate Research Physician at NIH. Resources for Researchers New Funding Opportunities Limited Competition: Interdisciplinary Complementary and Integrative Health Clinical Research Training (T90/R90 Independent Clinical Trial Not Allowed) Notice of Change to Key Dates for RFA-NS-18-014 "BRAIN Initiative: Targeted BRAIN Circuits Planning Projects - TargetedBCPP (R34 Clinical Trial Not Allowed)" Notice of Change to Key Dates for RFA-NS-19-016 "HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)" Notice of Change to Key Dates for RFA-NS-19-017 "HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)" Notice of Change to Key Dates for RFA-NS-19-018 "HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)" HEAL Initiative: Early Phase Pain Investigation Clinical Network - Specialized Clinical Centers (U24 Clinical Trial Not Allowed) Focused Technology Research and Development (R01 - Clinical Trial Not Allowed) Exploratory Research for Technology Development (R21 - Clinical Trial Not Allowed) BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) Notice of Availability of Administrative Supplements for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project (Administrative Supplement/ Clinical Trial Optional) BRAIN Initiative: Tools to Facilitate High-Throughput Microconnectivity Analysis (R01 Clinical Trial Not Allowed) Special Journal Issue Focuses on Minority Health and Health Disparities In a special issue of the American Journal of Public Health, the National Institute on Minority Health and Health Disparities (NIMHD) presents 30 research strategies to chart a new course to advance minority health and health disparities research. Upcoming Events Gut Microbes in a Disruptive Age May 9, 2019 at 11 a.m. ET; Lipsett Amphitheater, NIH Clinical Center, NIH campus, Bethesda, MD Maria Gloria Dominguez-Bello, Ph.D., will deliver this lecture about the colonization of infants with live microbes acquired during their mother’s labor; the effects of factors that impair neonatal colonization (such as C-section); and the effects of modern antimicrobial practices on developmental phenotypes. Save the Date! NCCIH 20th Anniversary Symposium On Monday, September 23, 2019, NCCIH will host a 1-day research symposium to celebrate the Center’s 20th anniversary. This event will celebrate progress in complementary and integrative health research and look to the future of the field. The day will feature a Straus Distinguished Lecture by Dr. Lorimer Moseley of the University of South Australia, lightning round presentations with early-stage investigators, and two panel discussions on pain research in military and veteran populations as well as the future of natural products research.